dialysis strategies and pharmacological management of hypertension. Background. The tenet that peritoneal dialysis is capable of either normalizing or improving blood pressure Key words: ambulatory blood pressure monitoring; control in uraemic patients is based on outdated or antihypertensive therapy; prevalence of hypertension; monocentric experiences. Therefore, we assessed the peritoneal dialysis; white-coat hypertension prevalence of hypertension and the efficacy of antihypertensive therapy in a large, multicentric cohort of patients on peritoneal dialysis.
transversal, observational, multicentre study. All patients on and loaded into a general file, and the statistical processing was performed using the SPSS statistical package (SPSS Inc., peritoneal dialysis for at least 3 months and without peritonitis episodes or changes in dialysis technique for at least 1 Chicago, USA). A multivariate analysis was performed by using MANOVA (dependent variables: SBP and DBP values; month were considered eligible. Exceptions included cases in which an adequate ambulatory blood pressure monitoring independent variables: gender, peritoneal dialysis technique and recombinant human erythropoietin therapy (rHuEpo); recording was not possible due to arrhythmia (frequent extrasystoles, chronic atrial fibrillation), those with a differ-covariates, age and peritoneal dialysis duration) and logistic regression (dependent variable: hypertension according to ential BP <20 mmHg or >90 mmHg, or patients engaged in heavy physical work. Patient consent was required. The WHO criteria; qualitative and quantitative independent variables as in MANOVA). The linear regression analysis was first 30 consecutive and consenting subjects in each centre were enrolled in the study. A monitor of the study confirmed used to evaluate the relationships between age and DBP levels (the only significant correlation found with the multivathat the appointment schedule of the patients was not altered before recruitment began. The patients selected for the study riate analysis) and between haemoglobin and BP levels. The x2 contingency tables were used to evaluate the possibility of were asked to visit the out-patient clinic of their peritoneal dialysis centres on pre-determined days between 8 and 10 a predominant gender in the whole population and the difference in the use of antihypertensive multitherapy between a.m. for BP measurement and ambulatory blood pressure monitoring evaluation.
rHuEpo nocturnal peritoneal dialysis. The distribution of the various peritoneal dialysis techniques was similar between genders. One hundred and ninety patients were treated with rHuEpo at the mean dose of 4539±2907 UI/week.
Antihypertensive therapy
Three hundred and sixty two patients (71.8% of the study population, 81.5% of the hypertensive patients) were on antihypertensive therapy; 181 patients were treated with one drug, 128 patients with two drugs, and 53 patients were taking three or more drugs. Calcium antagonists were the most widely used drugs (65.7%), followed by angiotensin-converting enzyme inhibitors (32.6%), clonidine (30.1%), beta-blockers (22.6%), vasodilators (13.0%), angiotensin II receptor A greater number of patients on rHuEpo therapy antagonists (1.9%) and a-methyldopa (1.1%). The were treated with two or more antihypertensive drugs comparison of the patient cards with the patient diaries (84 out of 190 vs 97 out of 314; x2=8.5, P<0.005). revealed that 4.7% of the patients did not adhere No relationship was found between haemoglobin and completely to the therapeutic prescription of the BP levels in either the whole population or in the two physicians.
groups of patients with and without rHuEpo therapy.
BP levels and prevalence of hypertension Ambulatory blood pressure monitoring evaluation Average office SBP and DBP values of the whole study Four hundred and fourteen out of the 504 ambulatory population were 147.8±24.3 and 85.0±12.2 mmHg, blood pressure monitoring recordings were valid and respectively. Four hundred and forty four patients suitable for analysis. The causes of failure in the other (88.1% of the whole population) were hypertensive 90 cases were: one or more hours without BP readings according to WHO/ISH criteria, and, with JNC staging in 90 cases, ambulatory blood pressure monitoring criteria, 368 out of the 504 patients (73% of the duration <24 h in 27 cases and <75% of the expected population) were hypertensive, with moderate to severe number of readings in 22 cases. The 24 h mean values hypertension being found in 188 cases ( Table 2) .
of SBP and DBP were 139.0±19.4 and 80.6± A residual hypertension (SBP Á140 mmHg, or DBP 10.8 mmHg; the mean values were 140.7±19.6 and Á90 mmHg) was present in the 286 out of the 362 82.1±11.0 mmHg during the daytime, and 132.0±21.3 patients on antihypertensive therapy, and 82 hypertens-and 74.4±11.4 mmHg at night time, respectively. ive patients were off antihypertensive therapy.
Two hundred and eighty two out of 414 patients Multiple regression analysis showed that the only (69.3% of the population with a valid ambulatory blood pressure monitoring recording) had a patholostatistically significant relationship among the variables gical BP load. Among the patients on antihypertensive studied was between age and DBP levels (F=39.6, therapy, BP load evaluation revealed residual hyperten-P<0.001). The linear regression analysis showed a sion in 235 out of 304 patients and it agreed with the negative correlation between these two parameters: office BP evaluation in 243 patients (37 with BP r=−0.27, P<0.001.
control, 206 with poor BP control ) and disagreed in Figure 1 shows the average SBP and DBP values the other 61 patients (32 with hypertension according for successive decades of life. With advancing age, SBP to office BP evaluation and normal BP load, 29 with levels remained substantially stable and DBP levels normotension according to office BP evaluation and tended to diminish progressively.
pathological BP load ). The McNemar's test showed No differences in the use of antihypertensive drugs that the disagreement between JNC staging and BPL were found with respect to gender, age, peritoneal evaluation was not significant. dialysis technique and peritoneal dialysis duration.
Among the hypertensive patients off drugs, whitecoat hypertension was identified in six out of 66 cases. Italian peritoneal dialysis population, represents one Despite the wide use of effective antihypertensive drugs, the majority of patients (79%) had residual of the largest and most recent epidemiological investihypertension. On the other hand, the lack of treatment gations on hypertension in ESRD patients treated with of one out of five hypertensive patients does not seem peritoneal dialysis. The number of centres involved to be justified, as white-coat hypertension was a rare (~25% of the main Italian centres) and the large event in our population. sample sizes of the study provide a fairly realistic Based on BP load calculations using the two BP picture of the prevalence of hypertension in patients measurement techniques, ambulatory blood pressure in Italy.
monitoring does not seem to provide any real advant-A large percentage (88.1%) of peritoneal dialysis age over sphygmomanometric measurement in evaluatpatients were hypertensive according to WHO/ISH ing who should be treated and when treatment should criteria, and JNC staging documented poor BP control be changed. However, the high prevalence of nonin 73% of the study population, with moderate to dippers found in our peritoneal dialysis population is severe hypertension in half of the hypertensive patients.
worthy of study and deserves a longitudinal evaluation, The prevalence of hypertension was much higher since several studies have already documented that than in the healthy population [8] . This difference may cardiovascular complications due to hypertension are be partially accounted for by the advanced age of our greater in non-dippers than in dippers [14] . population (almost half of the patients were elderly).
In conclusion, the data of this epidemiological It is interesting to note, however, that the younger investigation document the fact that BP control in subjects seemed to behave like the older patients with peritoneal dialysis patients, described in the past as respect to BP levels and hypertension, with an interfersatisfactory and easy to achieve, is today more a 'myth' ence of gender and age substantially different from than a 'reality'. These figures cast doubts on the that of the healthy population. Ageing was associated effectiveness of our current peritoneal dialysis strategies with decreasing DBP levels beginning in the first decand pharmacological management of hypertension, ades of life, whereas in the healthy population, this and should stimulate further studies aimed at evaluatphenomenon is not observed until the seventh decade ing the clinical outcomes over a period of time. of life. Moreover, SBP levels were high and stable for all the decades of life, differing from the healthy Although a comparison with the PD-CIS report [9] Albertazzi A, Del Rosso G; Cuneo: Ghezzi P, Meinero S; Desio: is limited by differences in age, nationality and race Surian G, Scanziani R; Florence S. Maria Annunziata: Maggiore Q, distribution, our findings are similar to, or even more Sisca S; Gallarate: Cantù P, Limido A; Genoa Sampierdarena: Cappelli G, Ratto G; Ivrea: Giacchino F, Belardi P; Milan S. Carlo: disheartening than, those contained in the report. our results are similar to those recently found by Salem Maschio G, Lupo A; Vigevano: Bellazzi R, Romanini D; Vimercate: in a large haemodialysis population [10] suggesting Sessa A, Tommasi A. that peritoneal dialysis does not offer any advantage over haemodialysis with respect to BP control.
In contrast to a previous report [ Our data also showed a negative impact of rHuEpo rHuEpo. This effect did not appear to be mediated by 9: 1-11 the level of haemoglobin, and could be explained 
